China's Rare Disease Data Center promises ¥200 billion of unmet demand, yet many startups claim it drags their pipelines. Discover why the engine meant to accelerate innovation could be grinding them down.
For further actions, you may consider blocking this person and/or reporting abuse
Top comments (0)